Cheri Mullaney has worked in the finance and accounting industry since 1995. Cheri began their career as a Senior Auditor at Kennedy & Lehan, followed by a role as an Audit Professional at Kirkland Albrecht & Fredrickson. In 1998, they moved to Sager Electronics as an Accounting Supervisor. At GateHouse Media, they held two roles, first as a Financial Analyst and then as a Corporate Accounting Manager. In 1999, they joined Smiths Medical as a Financial Business Partner for the Global Products division, and then as a Senior Financial Analyst for the Commercial division. In 2015, they moved to Haemonetics as a Finance Business Partner and a Finance Consultant for the Plasma Franchise. In 2018, they joined NIGHTSTAR THERAPEUTICS as a Senior Manager of Financial Planning & Analysis, and in 2019 they began as a Senior Manager Clinical Financial Planner at Biogen. Most recently, they are an Associate Director of Financial Planning & Analysis at Q32 Bio Inc.
Cheri Mullaney obtained a Bachelor of Science degree in Accounting and Finance from Clarkson University in 1994. Cheri also holds a Certified Public Accountant certification in the State of Massachusetts (inactive) from the AICPA.
This person is not in any offices